Hints and tips:
Related Special Reports
...Many cannabis companies have struggled to raise funding owing to rules, including from the UK’s Financial Conduct Authority, that prevent investment into groups that make money selling recreational drugs...
...Miels said that the pharmaceutical company has since “rebuilt” its business in China....
...The practice is currently limited to a small number of companies, including Illumina and Allelica, and its use is not yet widespread....
...A Swiss pharmaceutical group has scrapped plans to conduct a major drug trial in the UK, damaging government efforts to showcase the country as an attractive destination for investment in life sciences after...
...He also told Wen his family’s background was in horseracing and pharmaceuticals, the jury heard....
...Some NHS staff need to “get over cultural sniffiness” about profit motives to work with pharmaceutical and tech companies to reverse the steep drop in UK clinical trials, shadow health secretary Wes Streeting...
...AstraZeneca has acquired oncology biotech Fusion Pharmaceuticals for $2.4bn to build its expertise and challenge Swiss company Novartis in the developing field of a more targeted form of radiotherapy....
...The pharmaceutical industry is close to agreeing a deal with the UK government over drug pricing, according to the chief financial officer of Swiss drugmaker Novartis....
...But pharmaceutical companies can file several patents for single drugs at different times, delaying the entry of generic medicines....
...Aim biotech companies complain of liquidity constraints, high regulatory costs and limited access to funding....
...“Early diagnosis needs to be connected to treatment or it is pointless,” said Nick James, professor at the UK Institute of Cancer Research and leader of the work on prostate cancer....
..., and Merck and Novartis signing smaller deals on Monday....
...There is limited data to track shortages in lower- and middle-income countries. But they are unable to compete on price with richer nations....
...The list price of Wegovy is $1,349 in the US, 14 times above the UK price, Sanders noted....
...Under the VPAG deal, which comes into force in 2024, the pharmaceutical industry agreed to invest an additional £400mn over five years through the UK life sciences investment programme “to drive forward...
..., food technology, pharmaceuticals and green tech....
...The US is the largest pharmaceutical market, mainly because it pays the most in the world for drugs....
...US pharma giant Eli Lilly is also expanding supplies of its weight loss drug Mounjaro, which the UK approved in November. Supply shortages are not limited to the UK....
...The project highlighted the UK’s role as a global pioneer in the field of genome sequencing, according to scientists....
...This offers an opportunity to revise the arrangement — which a report for the Association of the British Pharmaceutical Industry estimated will otherwise cost the UK £5.7bn in lost investment in research...
...In the UK, Wegovy is available in limited supply on the NHS but patients using private healthcare can pay up to £300 for a month’s supply. Costs are similar in Denmark and Germany....
...Several international funds took part in the Series A round, which was led by Novartis Venture Fund and includes follow-on investment by the Dementia Discovery Fund....
...This is aided by the fact that groups such as Novartis are based in the city, soon to be joined by AstraZeneca....
...But the proposal has run into opposition from the pharmaceutical industry....
International Edition